Stereotactic Body Radiation Therapy for Prostate Cancer Using Tomotherapy With Synchrony Fiducial Tracking

Numerous prospective and retrospective studies have demonstrated the efficacy and safety of stereotactic body radiation therapy (SBRT) for prostate cancer. Since SBRT utilizes a very tight margin, management of intrafraction prostate motion is necessary. As a real-time motion tracking and correction...

Descripción completa

Detalles Bibliográficos
Autores principales: Shintani, Takashi, Anami, Shimpei, Sano, Keisuke, Okada, Wataru, Tanooka, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Medical Physics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362472/
https://www.ncbi.nlm.nih.gov/pubmed/37485140
http://dx.doi.org/10.7759/cureus.40778
_version_ 1785076430901608448
author Shintani, Takashi
Anami, Shimpei
Sano, Keisuke
Okada, Wataru
Tanooka, Masao
author_facet Shintani, Takashi
Anami, Shimpei
Sano, Keisuke
Okada, Wataru
Tanooka, Masao
author_sort Shintani, Takashi
collection PubMed
description Numerous prospective and retrospective studies have demonstrated the efficacy and safety of stereotactic body radiation therapy (SBRT) for prostate cancer. Since SBRT utilizes a very tight margin, management of intrafraction prostate motion is necessary. As a real-time motion tracking and correction system (Synchrony; Accuray, Sunnyvale, CA) has been introduced in the newer platform of tomotherapy (Radixact; Accuray), Radixact can deliver tracking SBRT. In the case report, we present the first clinical experience with prostate SBRT using tomotherapy with Synchrony fiducial tracking.
format Online
Article
Text
id pubmed-10362472
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-103624722023-07-23 Stereotactic Body Radiation Therapy for Prostate Cancer Using Tomotherapy With Synchrony Fiducial Tracking Shintani, Takashi Anami, Shimpei Sano, Keisuke Okada, Wataru Tanooka, Masao Cureus Medical Physics Numerous prospective and retrospective studies have demonstrated the efficacy and safety of stereotactic body radiation therapy (SBRT) for prostate cancer. Since SBRT utilizes a very tight margin, management of intrafraction prostate motion is necessary. As a real-time motion tracking and correction system (Synchrony; Accuray, Sunnyvale, CA) has been introduced in the newer platform of tomotherapy (Radixact; Accuray), Radixact can deliver tracking SBRT. In the case report, we present the first clinical experience with prostate SBRT using tomotherapy with Synchrony fiducial tracking. Cureus 2023-06-22 /pmc/articles/PMC10362472/ /pubmed/37485140 http://dx.doi.org/10.7759/cureus.40778 Text en Copyright © 2023, Shintani et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Medical Physics
Shintani, Takashi
Anami, Shimpei
Sano, Keisuke
Okada, Wataru
Tanooka, Masao
Stereotactic Body Radiation Therapy for Prostate Cancer Using Tomotherapy With Synchrony Fiducial Tracking
title Stereotactic Body Radiation Therapy for Prostate Cancer Using Tomotherapy With Synchrony Fiducial Tracking
title_full Stereotactic Body Radiation Therapy for Prostate Cancer Using Tomotherapy With Synchrony Fiducial Tracking
title_fullStr Stereotactic Body Radiation Therapy for Prostate Cancer Using Tomotherapy With Synchrony Fiducial Tracking
title_full_unstemmed Stereotactic Body Radiation Therapy for Prostate Cancer Using Tomotherapy With Synchrony Fiducial Tracking
title_short Stereotactic Body Radiation Therapy for Prostate Cancer Using Tomotherapy With Synchrony Fiducial Tracking
title_sort stereotactic body radiation therapy for prostate cancer using tomotherapy with synchrony fiducial tracking
topic Medical Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362472/
https://www.ncbi.nlm.nih.gov/pubmed/37485140
http://dx.doi.org/10.7759/cureus.40778
work_keys_str_mv AT shintanitakashi stereotacticbodyradiationtherapyforprostatecancerusingtomotherapywithsynchronyfiducialtracking
AT anamishimpei stereotacticbodyradiationtherapyforprostatecancerusingtomotherapywithsynchronyfiducialtracking
AT sanokeisuke stereotacticbodyradiationtherapyforprostatecancerusingtomotherapywithsynchronyfiducialtracking
AT okadawataru stereotacticbodyradiationtherapyforprostatecancerusingtomotherapywithsynchronyfiducialtracking
AT tanookamasao stereotacticbodyradiationtherapyforprostatecancerusingtomotherapywithsynchronyfiducialtracking

Ejemplares similares